What does the COVID-19 pandemic mean for rheumatology now and in the future?

The global COVID-19 pandemic has thrown up many challenges for rheumatologists. From the potential risk posed to their patients to the impact the pandemic has had on the delivery of care.

Join us and a leading panel of experts as we explore the ways rheumatologists have adapted to these challenges. With a live cross to London, we’ll speak to Dr. James Galloway, a consultant who was redeployed to the frontline at the height of the pandemic. He will describe how COVID-19 has changed rheumatology practice in the UK and how the lessons learnt will impact clinical practice in the future.

Hosted by

Professor Catherine Hill
President, Australian Rheumatology Association. Director, Rheumatology Unit, The Queen Elizabeth Hospital. Staff Specialist, Royal Adelaide Hospital. Clinical Professor, University of Adelaide. Chair, South Australian Medicine Evaluation Panel.

*Disclosure statement: Prof. Hill will receive no remuneration of any kind for her participation in this webinar.

With Special Guests

Doctor James Galloway
Clinical lecturer and honorary consultant rheumatologist King’s College London and head of biologics assessment service. Senior investigator on a national platform trial for COVID-19 investigating baricitinib and ravilibumab

Associate Professor Philip C. Robinson
Chair of the steering committee for the COVID-19 Global Rheumatology Alliance. Associate Professor at the faculty of medicine, University of Queensland. Senior Staff Specialist in Rheumatology, Royal Brisbane Hospital.

There will be an opportunity to ask the panel questions. The webinar will be available on demand after the event.

This webinar was developed independently by the limbic. Thank you to Pfizer Australia Pty Ltd for providing the financial support that made it possible.

Already a member?

Login to keep reading.

Email me a login link

© 2022 the limbic